Download PDF
Thromb Haemost 1994; 72(01): 132-139
DOI: 10.1055/s-0038-1648824
Original Article
Schattauer GmbH Stuttgart

Adenosine Nucleotides and Serotonin Stimulate von Wille-brand Factor Release from Cultured Human Endothelial Cells

D S Palmer
1   The Ottawa Centre, Canadian Red Cross Society, Blood Transfusion Service, Ottawa, Ontario, Canada
,
M T Aye
2   National Office, Canadian Red Cross Society, Blood Transfusion Service, Ottawa, Ontario, Canada
3   The Depts. of Medicine, Faculty of Medicine, University of Ottawa, Ontario, Canada
,
P R Ganz
1   The Ottawa Centre, Canadian Red Cross Society, Blood Transfusion Service, Ottawa, Ontario, Canada
4   Depts. of Biochemistry, Faculty of Medicine, University of Ottawa, Ontario, Canada
,
M Halpenny
1   The Ottawa Centre, Canadian Red Cross Society, Blood Transfusion Service, Ottawa, Ontario, Canada
,
S Hashemi
2   National Office, Canadian Red Cross Society, Blood Transfusion Service, Ottawa, Ontario, Canada
3   The Depts. of Medicine, Faculty of Medicine, University of Ottawa, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Received 04 August 1993

Accepted after revision 02 March 1994

Publication Date:
26 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Endothelial cells (ECs) synthesize and release von Willebrand factor (vWf) either constitutively or from Weibel-Palade bodies by a regulated pathway. Although stimulated release of vWf from ECs occurs following exposure to thrombin, histamine, interleukin, tissue necrosis factor and fibrin in vitro, these agents are unlikely to be present in physiologically relevant concentrations during the initial stages of primary hemostasis. Alternatively, agents known to be released from the dense granules of activated platelets at the sites of vascular injury may provide the initial physiological stimuli for vWf release from ECs in vivo. We have examined the effects of the platelet secretagogues ADP, AMP, ATP and serotonin on the release of vWf from ECs and demonstrated enhanced release in all cases. The extent and time at which optimum vWf release was observed depended on the agonist and its concentration. At 3 nM, optimum release occurred after 4 hours with ADP (330 %/ml) or 1 h with AMP (153%/ml) or ATP (450%/ml). At 30 nM, optimum release was seen after 1 hour with ADP (315 %/ml) or AMP (595%/ml) and after 15 min with ATP (938%/ml). With serotonin, optimal release was seen by 30 min at 0.3 μM (1034%/ml) and after 1 h at 1 pM (745%/ml) although the response after 15 min was nearly equivalent (667%/ml). The doses giving 50% of maximal response (ED50) after 1 h were 6.5 nM (ADP), 15.2 nM (AMP) and 2.4 nM (ATP) and 20 nM for ATP or 75 nM for serotonin after 15 or 30 min respectively. ADP also enhanced PGI2 release from ECs in a dose- and time-dependent manner. These observations support a mechanism whereby activated platelets, which interact with and bind to ECs or subendothelium and release adenine nucleotides or serotonin from platelet dense granules, could stimulate the release of vWf from adjacent ECs thereby enhancing EC-platelet interactions and facilitating primary hemostasis.

 

  • References

  • 1 Ruggeri ZM. Functional domains of von Willebrand factor involved in interactions with platelets and the subendothelium. In: Platelet membrane-receptors: Molecular biology, immunology, biochemistry and pathology Jamieson GA. (ed) Alan R. Liss, Inc; New York, NY: 1988: 219-253
  • 2 Handin RI, Wagner DD. Molecular and cellular biology of von Willebrand factor. In: Progress in hemostasis and thrombosis Coller BS. (ed) W. B. Saunders Co; Philadelphia, PA: Vol. 9 1989: 233-259
  • 3 Meyer D, Girma J-P. von Willebrand factor: structure and function. Thromb Haemost 1993; 70: 99-104
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Sadler JE, Davie EW. Hemophilia A, hemophilia B and von Willebrand’s disease. In: The molecular basis of blood diseases Stamatoyannopoulos G, Nienhuis A, Leder P, Majerus PW. (eds) W. B. Saunders Co; Philadelphia, PA: 1987: 575-630
  • 5 Zimmerman TS, Ruggeri ZM, Fulcher CA. Factor VUI/von Willebrand factor. In: Progress in Hematology Brown EB. ed Grune and Stratton; New York, NY: Vol. XIII 1983: 279-309
  • 6 Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII in patients with von Willebrand’s disease. J Clin Invest 1977; 60: 390-404
    CrossrefPubMedGoogle Scholar
  • 7 Brinkhous KM, Sandberg H, Garris JB, Mattsson C, Palm M, Griggs T, Read MS. Purified human factor VIII procoagulant protein: Comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci 1985; 82: 8752-8756
    CrossrefPubMedGoogle Scholar
  • 8 Wagner D. The Weibel-Palade body: the storage granule for von Willebrand factor and P-Selectin. Thromb Haemost 1993; 70: 105-110
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Nachman RL, Jaffe EA. Subcellular platelet Factor VIII antigen and von Willebrand factor. J Exp Med 1975; 141: 1101-1113
    CrossrefPubMedGoogle Scholar
  • 10 Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Heliums JD. Involvement of large plasma von Willebrand factor (vWf) multimers and unusually large vWf forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 12: 1456-1461
    PubMedGoogle Scholar
  • 11 Girma J-P, Meyer D, Cornelis LV, Pannekoek H, Sixma JJ. Structure-function relationship of human von Willebrand factor. Blood 1987; 70: 605-611
    PubMedGoogle Scholar
  • 12 Data RE, Williams SB, Roberts DD, Gralnick HR. Platelets adhere to sul-fatides by von Willebrand factor dependent and independent mechanisms. Thromb Haemost 1991; 65: 581-587
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Buchanan MR, Richardson M, Haas TA, Hirsh J, Madri JA. The basement membrane underlying the vascular endothelium is not thrombogenic: In vivo and in vitro studies with rabbit and human tissue. Thromb Haemost 1987; 58: 698-704
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Lahav J, Schwartz MA, Hynes RO. Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: Interaction of thrombospondin with fibronectin and collagen. Cell 1982; 31: 253-262
    CrossrefPubMedGoogle Scholar
  • 15 Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol 1990; 6: 217-246
    CrossrefPubMedGoogle Scholar
  • 16 Schorer AE, Moldow CF, Rick ME. Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells. Brit J Haematol 1987; 67: 193-197
    CrossrefPubMedGoogle Scholar
  • 17 Hashemi S, Tackaberry ES, Palmer DS, Ganz PR. DD A VP-induced release of von Willebrand factor from endothelial cells in vitro: The effect of plasma and blood cells. Biochem Biophys Acta 1990; 1052: 63-70
    CrossrefPubMedGoogle Scholar
  • 18 Mannucci PM. Desmopressin (DDAVP) for treatment of disorders of hemostasis. In: Progress in hemostasis and thrombosis Coller BS. (ed) Grune and Stratton; Vol 8 1986: 19-45
  • 19 Moffat EH, Giddings JC, Bloom AL. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions of factor VIII and possible endothelial cell (EC) related activities. Br J Haematol 1984; 57: 651-662
    CrossrefPubMedGoogle Scholar
  • 20 Booyse FM, Osikowicz G, Feder S. Effects of various agents on ristocetin-Willebrand factor activity in long-term cultures of von Willebrand and normal human umbilical vein endothelial cells. Thromb Haemost 1981; 46: 668
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Hashemi S, Palmer DS, Aye MT, Ganz PR. Platelet-activating factor secreted by DD A VP-treated monocytes mediates von Willebrand factor release from endothelial cells. J Cell Physiol 1993; 154: 496-505
    CrossrefPubMedGoogle Scholar
  • 22 Hashemi S, Palmer DS, Aye MT, Ganz PR. Molecular mechanisms of cellular responses to DDAVP. In: Desmopressin in bleeding disorders Mariani G, Mannucci PM, Cattaneo M. (eds) NATO-ASI Series A, Plenum Publishing Corp; New York, NY: 1993. 242 43-56
  • 23 Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA. Studies of human platelet a-granule release in vivo. Blood 1981; 58: 607-618
    PubMedGoogle Scholar
  • 24 Kaplan KL, Dauzier MJ, Rose S. ADP and epinephrine-induced release of platelet fibrinogen. Blood 1976; 48: 797-802
    PubMedGoogle Scholar
  • 25 Vanhoutte PM. Platelet-derived serotonin, the endothelium, and cardiovascular disease. J Cardiovasc Pharmacol 1991; 17: S6-S12
    CrossrefPubMedGoogle Scholar
  • 26 Newby AC, Henderson AH. Stimulus-secretion coupling in vascular endothelial cells. Annu Rev Physiol 1990; 52: 661-674
    CrossrefPubMedGoogle Scholar
  • 27 van Coevorden A, Boeynaems JM. Physiological concentrations of ADP stimulate the release of prostacyclin from bovine aortic endothelial cells. Prostaglandins 1984; 27: 615-626
    CrossrefPubMedGoogle Scholar
  • 28 McIntyre TM, Zimmerman GA, Satoh K, Prescott SM. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin and adenosine triphosphate. J Clin Invest 1985; 76: 271-280
    CrossrefPubMedGoogle Scholar
  • 29 Weigel G, Griesmacher A, Muller MM. Regulation of eicosanoid release in human umbilical endothelial cells. Thromb Res 1991; 62: 685-695
    CrossrefPubMedGoogle Scholar
  • 30 Levine JD, Harlan JM, Harker LA, Joseph ML, Counts RB. Thrombin-mediated release of Factor VIII antigen from human umbilical vein endothelial cells in culture. Blood 1982; 60: 531-534
    PubMedGoogle Scholar
  • 31 Lopez JAG, Armstrong ML, Adams BrothertonAF, Piegors DJ, Heistad DD. Effects of atherosclerosis and regression on vascular responses to products of activated products in primates. Am J Physiol 1991; 260 (Heart Circ Physiol 29) H1051-H1056
    PubMedGoogle Scholar
  • 36 Harrison RL, McKee PA. Estrogen stimulates von Willebrand factor production by cultured endothelial cells. Blood 1984; 63: 657-665
    PubMedGoogle Scholar
  • 33 De Clerck F, David JL, Janssen PAJ. Serotonergic amplification mechanisms in blood platelets. In: 5-Hydroxytryptamine in peripheral reactions De Clerck F, Vanhoutte PM. (eds) Raven Press; New York: 1982: 83-94
  • 34 Shepro D, Dunham B. Endothelial cell metabolism of biogenic amines. Annp Rev Physiol 1986; 48: 335-345
    PubMedGoogle Scholar
  • 35 Charles A, Rounds S, Farber HW. Neutrophil chemoattractant production by cultured serotonin-stimulated bovine and human endothelial cells. Am J Physiol 1991; 261 (Lung Cell Mol Physiol 5) L133-L139
    PubMedGoogle Scholar
  • 36 Gordon JL. Purine receptors on endothelial cells. In: Vascular endothelium: Receptors and transduction mechanisms Catravas JD, Gillis CN, Ryan US. (eds) Plenum Press; New York, NY: NATO ASI Series Vol 175 1989: 69-75
  • 37 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756
    CrossrefPubMedGoogle Scholar
  • 38 Zimmerman TS, de la Pointe LI, Edgington TS. Interaction of Factor VIII antigen in hemophilic plasmas with human antibodies to Factor VIII. J Clin Invest 1977; 59: 984-989
    CrossrefPubMedGoogle Scholar
  • 39 Mayadas TN. Von Willebrand factor and P-Selectin targeting to and release from endothelial cell-specific storage granules. In: Desmopressin in bleeding disorders. Mariani G, Mannucci PM, Cattaneo M. (eds) Plenum Press; New York, NY: NATO ASI Series A; Vol 242 1993: 13-25
  • 40 Weintraub WH, Negulescu PA, Machen TE. Calcium signalling in endo-thelia: cellular heterogeneity and receptor internalization. Am J Physiol 1992; 263 (Cell Physiol 32) C1029-C1039
    CrossrefPubMedGoogle Scholar
  • 41 Gordon EL, Pearson JD, Slakey LL. The hydrolysis of extracellular adenine nucleotides by cultured endothelial cells from pig aorta: Feed-forward inhibition of adenosine production at the cell surface. J Biol Chem 1986; 261: 15496-15504
    PubMedGoogle Scholar
  • 42 Klee A, Seiffge D. Evaluation of pulmonary accumulation of ^Chromium-labelled rat platelets following intravenous application of ADP and collagen. Thromb Haemost 1991; 65: 588-595
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Hara H, Osakabe M, Kitajima A, Tamao Y, Kikumoto R. MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist. Thromb Haemost 1991; 65: 415-420
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Meyers KM, Holmsen H, Seachord CL. Comparative study of platelet dense granule constituents. Am J Physiol 1982; 243 (Regulatory Integrative Comp Physiol 12) R454-R461
    PubMedGoogle Scholar
  • 45 Chesney CM, Pifer DD, Byers LW, Muirhead EE. Effect of platelet-activating factor (PAF) on human platelets. Blood 1982; 59: 582-585
    PubMedGoogle Scholar
  • 46 Camussi GM, Aglietta GM, Malavasi F, Tetta C, Piacibello W, Sanavio F, Bussolino F. The release of platelet-activating factor from human endothelial cells in culture. J Immunol 1983; 131: 2397-2403
    PubMedGoogle Scholar
  • 47 Hartig P, Kao H-T, Macchi M, Adham N, Zgombick J, Weinshank R, Bran-chek T. The molecular biology of serotonin receptors. An overview. Neuropsychopharmacology 1990; 3: 335-347
    PubMedGoogle Scholar
  • 48 Prescott SM, McIntyre TM, Zimmerman GA. The role of platelet-activating factor in endothelial cells. Thromb Haemost 1990; 64: 99-103
    Article in Thieme ConnectPubMedGoogle Scholar
  • 49 Tranquille N, Emeis JJ. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region. Thromb Haemost 1990; 63: 454-458
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Braquet P, Paubert-Braquet M, Bourgain RH, Bussolino F, Hosford D. PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection. J Lipid Mediat 1989; 1: 75-112
    PubMedGoogle Scholar
  • 51 Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: A juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991; 115: 223-234
    CrossrefPubMedGoogle Scholar
  • 52 Dikranian K, Stoinov N. Effect of vasoactive amines on Weibel-Palade bodies in capillary endothelial cells. Experientia 1991; 47: 830-832
    CrossrefPubMedGoogle Scholar